Түз ичегинин рак оорусунун кайталанышы

Бул билдирүүнү бөлүшүү

How to prevent recurrence of colorectal cancer ? How to treat recurrence of colorectal cancer after surgery ?

Colorectal cancer is a common malignant tumor, including colon and rectal cancer. The incidence of colorectal cancer from high to low is the rectum, sigmoid colon, ascending colon, descending colon, and transverse colon. In recent years, there has been a trend toward the proximal (right colon).

If colorectal cancer is detected early, it can usually be cured.

5-year survival rate for colorectal cancer

According to US ASCO official website data, the 5-year survival rate of colorectal cancer patients is 65%. However, the survival rate of colorectal cancer may vary depending on a number of factors, especially the stage.

For colon cancer, the overall 5-year survival rate is 64%. 5-year survival rate for localized colon cancer is 90%; 5-year survival rate is 71% for metastasis to surrounding tissues or organs and / or regional lymph nodes; 5-year survival rate is 14% for colon cancer that has occurred distant .

For rectal cancer, the overall 5-year survival rate is 67%. The 5-year survival rate for localized rectal cancer is 89%; the 5-year survival rate is 70% for metastases to surrounding tissues or organs and / or regional lymph nodes. If distant metastases occur in rectal cancer, the 5-year survival rate is 15%.

The current treatments for colorectal cancer include surgery, chemotherapy, radiotherapy, targeted therapy, and immunotherapy. Surgery is the preferred way to cure colorectal cancer. But Vicki, a cancer-free home editor, learned that about 60% to 80% of patients with rectal cancer will relapse within 2 years after surgery.

How to effectively prevent recurrence of colorectal cancer ?

Жашоо образыңызды жакшыртыңыз

Ичкиликти ташта, арак ташта, ичкиликти ташта, маанилүү нерселер үч жолу айтылат, спирт ичимдиктерин ташташ керек. Ошондой эле тамеки тартпаңыз, ашыкча иштебеңиз жана бактылуу болуңуз.

Тиешелүү машыгуу, операциядан 2-3 ай өткөндөн кийин, жөө басуу сыяктуу жумшак көнүгүүлөрдү жасап, акырындык менен 15 мүнөттөн 40 мүнөткө чейин көбөйтүүгө болот; ошондой эле цигонг, тай чи, радио көнүгүүлөр жана башка жумшак көнүгүүлөрдү жасай аласыз.

Диетага өзгөчө көңүл буруу керек, көгөргөн тамактарды, барбекю, бекон, тофу жана нитрит камтылган башка тамактарды жебегиле, ошондой эле салттуу кытай дарыларын жана ден-соолукка пайдалуу азыктарды жебегиле.

Операциядан кийинки диета негизинен жеңил, ал эми жумуртканын агы жана майсыз эт сыяктуу жогорку сапаттагы белоктун керектөөсү көбөйтүлөт. Операциядан кийинки диета көбүнчө суудан, боткодон, сүттөн, бууланган жумурткадан, балыктан, арык эттен кадимки диетага өтөт.

Оңой сиңүүчү тамактарды жегенге аракет кылыңыз, майлуу, ачуу, дүүлүктүрүүчү, катуу, жабышчаак жана башка тамактардан алыс болуңуз, салмактуу тамактаныңыз, азыраак тамактаныңыз жана толук болбошуңуз керек.

Regular consumption of nuts such as cashews, hazelnuts, walnuts, almonds, and walnuts can reduce the recurrence rate of bowel cancer.

Postoperative care recommendations for colorectal cancer

The suture is completed 7-10 days after colon cancer. Elderly patients or patients with certain complications can appropriately extend the time of stitch removal. After stitch removal, they must pay attention to the cleanliness of the wound to avoid infection.

After the suture is removed, the dressing and abdominal bands should continue to be tightened during the wound healing until the surgical incision is completely healed, which takes about half a month.

The skin puller should be removed at least 10 days after the operation. The wound should be kept as clean and dry as possible to reduce sweating. You can take a shower, but you cannot rub the wound.

It is normal to have numbness around the wound after surgery, which will disappear after a while.

It is normal for wounds to exudate. A small amount can be used for local disinfection. Replace the dressing on the surface. However, if the amount of exudate is large and severe redness, swelling and pain occur, you should contact your doctor in time to treat the wound.

When the surgical incision is about to grow, it will feel itchy, commonly known as “long meat”. At this time, avoid scratching, do not get water, and avoid infection.

The wound is beyond the healing period, but it still does not grow well. You need to find a professional surgeon to handle it, change the medicine in time, clean the wound, and treat the infection. At the same time, pay attention to controlling blood sugar and strengthening nutrition.

Anal wounds usually take a month to heal. After healing, you can slowly practice squatting, 3-5 minutes each time, once in the morning and afternoon.

If the wound heals well, you can take a shower 7-14 days after removing the suture. You can use a body wash or soap, but avoid the wound.

Мезгил-мезгили менен карап чыгуу

According to statistics, the recurrence and metastasis rate of postoperative colon cancer in China is as high as 50%, and more than 90% of the recurrence and metastasis occur in 2-3 years after operation, and the recurrence rate is lower after 5 years. Therefore, surgery is not a one-time operation, and you must insist on regular review after surgery.

Patients with bowel cancer are most likely to have relapses within 3 years after surgery. During this period, the number of re-examinations should be relatively frequent; after 3 years, the re-examination interval can be appropriately extended.

Generally, it is reviewed every 3 months within 1 year after surgery; it is reviewed semi-annually in the first 2-3 years; and every 4-5 years. Specific review time also needs to find their own doctor to determine.

During the review, the items to be checked include:

Blood tests: blood routine, liver and kidney function, tumor markers (CEA, etc.);

Imaging examination: B-ultrasound, chest radiograph

Colonoscopy: performed 3 months after surgery to determine the healing of the surgical anastomosis and observe the polyps in other parts.

How to treat colon cancer recurrence after surgery ?

Экинчи хирургия

The most ideal method for recurrence of colorectal cancer patients after surgery is to remove the recurrent lesions to achieve the goal of radical cure. The first thing to do is to see if a second surgical resection can be performed. If the surgical criteria are met, the tumor can be surgically removed.

If there are multiple lesions, the invasion area is relatively large, or the distant metastases, if reoperation is prone to danger, and in the case that the surgical benefit is not guaranteed, other treatment methods can be selected.

Medication used in colon cancer treatment

Colon cancer chemotherapy drugs

Common chemotherapeutics are 5-fluorouracil, irinotecan, oxaliplatin, calcium folinate, capecitabine, tigio (S-1), and TAS-102 (trifluridine / tipiracil).

However, chemotherapy for colon cancer is usually a combination of several chemotherapeutics, and the common combination methods are:

1.FOLFOX (фторурацил, кальций фолинаты, оксалиплатин)

2.FOLFIRI (fluorouracil, calcium folinate, irinotecan)

3. CAPEOX (Капецитабин, Оксалиплатин)

4.FOLFOXIRI (fluorouracil, calcium folinate, irinotecan, oxaliplatin)

Colon cancer targeting drugs and immune drugs

1. KRAS / NRAS / BRAF wild-type targeted drugs: cetuximab or panitumumab (commonly used in left colon cancer)

2. Anti-angiogenesis inhibitors: bevacizumab or ramonizumab or ziv aflibercept

3. BRAF V600E targeted drugs: dalafenib + trimetinib; connetinib + bimetinib

4. NTRK fusion targeting drugs: Larotinib; Emtricinib

5.MSI-H (dMMR) PD-1: Paimumab; Navumab ± Ipilimumab

6.HER2-positive targeted drug: Trastuzumab + (Pertuzumab or Lapatinib)

In addition to surgery and radiotherapy for advanced colon cancer, systemic medication is an indispensable treatment stage. Fir
st-line treatment refers to the stage of first treatment with anticancer drugs, also called initial treatment. There are many choices for the first-line treatment of advanced colon cancer, usually based on chemotherapy.

However, the patient’s condition and physical condition must be distinguished. After a series of examinations, patients can be divided into two categories: patients who are suitable for high-intensity treatment and those who are not.

Drug selection for high-intensity treatment of colorectal cancer patients

Үч категорияга бөлүнөт:

First-line solutions with oxaliplatin

First-line solutions with irinotecan

(1) First-line plan containing oxaliplatin

FOLFOX ± бевацизумаб

CAPEOX ± Bevacizumab

FOLFOX + (cetuximab же panitumumab) (KRAS / NRAS / BRAF жапайы типтеги сол ичегинин рагы үчүн гана)

(B) the first-line plan containing irinotecan

FOLFIRI ± bevacizumab же

FOLFIRI + (cetuximab же panitumumab) (KRAS / NRAS / BRAF жапайы түрдөгү сол ичегинин рагы үчүн гана)

(III) First-line plan containing oxaliplatin + irinotecan

FOLFOXIRI ± Bevacizumab

Drug selection not suitable for high-intensity treatment in colorectal cancer

Биринчи катардагы дары-дармектердин варианттары

1. 5-фторурацил + кальций фолинат ± bevacizumab же куюу

2.Capecitabine ± Bevacizumab

3. Cetuximab or panitumumab) (Class 2B evidence, only for KRAS / NRAS / BRAF wild-type left colon cancer)

4. Navumab or Paimumab (only for dMMR / MSI-H)

5. Nivolumab + Ipilimumab (type 2B evidence, only applicable to dMMR / MSI-H)

6. Trastuzumab + (Pertuzumab or Lapatinib) (for tumors with HER2 amplification and RAS wild type)

1) After the above treatments, the functional status does not improve, and the best supportive treatment (palliative care) is selected;

2) After the above treatments, the functional state improves, and a high-strength initial plan can be considered.

Last medication choice in colorectal cancer

Rigfini

Трифторотимидин + типирацил

Best supportive care (palliative care)

Колдонулган адабияттар:

https://www.cancer.net/cancer-types/colorectal-cancer/statistics

https://zhuanlan.zhihu.com/p/42575420

https://www.nccn.org/professionals/physician_gls/default.aspx

 

Call +91 96 1588 1588 for details on colon cancer treatment or write to cancerfax@gmail.com.

Жазылуу Биздин туруу

Жаңыртууларды алыңыз жана Cancerfax блогун эч качан өткөрүп жибериңиз

Көбүрөөк изилдөө

Cytokine Release синдромун түшүнүү: себептери, симптомдору жана дарылоо
CAR T-Cell терапиясы

Cytokine Release синдромун түшүнүү: себептери, симптомдору жана дарылоо

Cytokine Release Syndrome (CRS) - бул иммунотерапия же CAR-T клетка терапиясы сыяктуу белгилүү бир дарылоо аркылуу пайда болгон иммундук системанын реакциясы. Бул цитокиндердин ашыкча чыгарылышын камтыйт, бул ысытма жана чарчоодон тартып органдын жабыркашы сыяктуу өмүргө коркунуч туудурган кыйынчылыктарга чейин симптомдорду жаратат. Башкаруу кылдат мониторинг жана кийлигишүү стратегияларын талап кылат.

CAR T Cell терапиясынын ийгилигинде фельдшерлердин ролу
CAR T-Cell терапиясы

CAR T Cell терапиясынын ийгилигинде фельдшерлердин ролу

Фельдшерлер CAR T-клетка терапиясынын ийгилигинде чечүүчү ролду ойнойт, бул дарылоо процессинде бейтаптын үзгүлтүксүз камын камсыз кылат. Алар ташуу учурунда маанилүү колдоо көрсөтүү, бейтаптардын маанилүү белгилерин мониторинг жүргүзүү, ошондой эле кыйынчылыктар пайда болсо, тез медициналык кийлигишүүлөрдү башкаруу. Алардын тез жооп кайтаруусу жана эксперттик кам көрүү терапиянын жалпы коопсуздугуна жана натыйжалуулугуна өбөлгө түзөт, саламаттыкты сактоо параметрлеринин ортосундагы жылмакай өтүүнү жеңилдетет жана өнүккөн уюлдук терапиянын татаал пейзажында пациенттин натыйжаларын жакшыртат.

Жардам керекпи? Биздин команда сизге жардам берүүгө даяр.

Сиздин жакын адамыңыздын тезирээк сакайып кетишин каалайбыз.

Чатты баштаңыз
Биз онлайнбыз! Биз менен баарлашыңыз!
Кодду скандаңыз
Салам,

CancerFax кош келиңиз!

CancerFax - бул алдыңкы баскычтагы рак оорусуна кабылган адамдарды CAR T-Cell терапиясы, TIL терапиясы жана дүйнө жүзү боюнча клиникалык сыноолор сыяктуу жаңы клетка терапиялары менен байланыштырууга арналган пионердик платформа.

Сиз үчүн эмне кыла аларыбызды бизге айтыңыз.

1) Ракты чет өлкөдө дарылообу?
2) CAR T-Cell терапиясы
3) Ракка каршы вакцина
4) Онлайн видеоконсультация
5) Протон терапиясы